Home SEC Filings

SEC Filings

Random

IHEARTMEDIA, INC. (OTCMKTS:IHRT) Files An 8-K Results of Operations and Financial Condition

ME Staff 8-k - August 3, 2017

GAIA, INC. (NASDAQ:GAIA) Files An 8-K Results of Operations and Financial Condition

ME Staff 8-k - May 1, 2017

MERIDIAN WASTE SOLUTIONS, INC. (OTCMKTS:MRDN) Files An 8-K Entry into a Material Definitive Agreement

ME Staff 8-k - April 27, 2017

Global Power Equipment Group Inc. (OTCMKTS:GLPW) Files An 8-K Entry into a Material Definitive...

ME Staff 8-k - June 1, 2017

AMPHENOL CORPORATION (NYSE:APH) Files An 8-K Other Events

ME Staff 8-k - March 22, 2017

Immunomedics,Inc. (NASDAQ:IMMU) Files An 8-K Other Events

ME Staff 8-k - January 25, 2017

NewLink Genetics Corporation (NASDAQ:NLNK) Files An 8-K Other Events

ME Staff 8-k - June 2, 2017

The China Fund, Inc. (NYSE:CHN) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - April 24, 2017

MercadoLibre, Inc. (NASDAQ:MELI) Files An 8-K Departure of Directors or Certain Officers; Election of...

ME Staff 8-k - April 7, 2017

SILVERCREST ASSET MANAGEMENT GROUP INC. (NASDAQ:SAMG) Files An 8-K Results of Operations and Financial...

ME Staff 8-k - May 4, 2017

12 3...4,317 Page 1 of 4,317

EDITOR PICKS

Wednesday’s Pipeline Movers: Bristol-Myers Squibb Company (NYSE:BMY) and Portola Pharmaceuticals Inc....

August 16, 2017

Two Failed Trials: Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) and Regeneron Pharmaceuticals, Inc....

August 15, 2017

Biotech Movers: Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

August 14, 2017

This Small Nasdaq Hidden Gem May Have a $2.8B Drug

July 16, 2017

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.